Pfizer (PFE) Tops Q1 EPS by 2c, Revenues Miss; Reaffirmed Guidance
Tweet
Share
E-mail
Get Alerts PFE Hot Sheet
Price: $27.80 -1.14%
Revenue Growth %: -4.6%
Financial Fact:
Discontinued operations--net of tax (in dollars per share): 0
Today's EPS Names:
TAYD, PKE, More
Revenue Growth %: -4.6%
Financial Fact:
Discontinued operations--net of tax (in dollars per share): 0
Today's EPS Names:
TAYD, PKE, More
Join SI Premium – FREE
Pfizer (NYSE: PFE) reported Q1 EPS of $0.77, $0.02 better than the analyst estimate of $0.75. Revenue for the quarter came in at $12.9 billion versus the consensus estimate of $13.15 billion.
Reaffirmed All Components of 2018 Financial Guidance:
- Revenues: $53.5 to $55.5 billion
- Adjusted Diluted EPS: $2.90 to $3.
For earnings history and earnings-related data on Pfizer (PFE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Pfizer's Litfulo meets Phase 3 endpoints for vitiligo treatment
- Integra LifeSciences cuts 2026 outlook after Cincinnati flood
- FactSet (FDS) Tops Q4 EPS by 17c, Beats on Revenue; Offers FY Guidance
Create E-mail Alert Related Categories
Earnings, Guidance, Hot EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
